Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with severe asthma according to internationally recognised guidelines (called the GINA guidelines)
- People who have received at least one dose of a biologic therapy (a specialised type of medication) for their asthma, including those who stopped taking it after just one dose
Who may not be able to join:
- People who have other significant lung or breathing conditions, such as tuberculosis (TB) that has caused serious lung damage, a history of having part or all of a lung surgically removed, or lung cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fanny WS Ko, MD, Chinese University of Hong Kong
Phone: 852 35053133
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To determine the prevalence and patterns of biologics utilization for severe asthma in Hong Kong.; To evaluate exacerbation rates before and after the initiation of biologic treatment.; To evaluate the asthma control before and after the initiation of biologic treatment.; To evaluate the lung function before and after the initiation of biologic treatment.; To explore whether physicians are following international guidelines for the prescription of biologics; To identify any adverse events associated with biologic therapy in the study population
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.